AR112457A1 - Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona - Google Patents

Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona

Info

Publication number
AR112457A1
AR112457A1 ARP180101984A AR112457A1 AR 112457 A1 AR112457 A1 AR 112457A1 AR P180101984 A ARP180101984 A AR P180101984A AR 112457 A1 AR112457 A1 AR 112457A1
Authority
AR
Argentina
Prior art keywords
methyl
pirazin
triazolo
derivatives
cyclopropyl
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR112457A1 publication Critical patent/AR112457A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP180101984 2017-08-02 2018-07-17 Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona AR112457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762540122P 2017-08-02 2017-08-02

Publications (1)

Publication Number Publication Date
AR112457A1 true AR112457A1 (es) 2019-10-30

Family

ID=63165529

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101984 AR112457A1 (es) 2017-08-02 2018-07-17 Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona

Country Status (8)

Country Link
US (1) US11180503B2 (https=)
EP (1) EP3661936B1 (https=)
JP (1) JP6850396B2 (https=)
CN (1) CN110914268B (https=)
AR (1) AR112457A1 (https=)
ES (1) ES2904938T3 (https=)
TW (1) TWI670271B (https=)
WO (1) WO2019027783A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11453673B2 (en) 2018-02-06 2022-09-27 Eli Lilly And Company Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors
AU2024341364A1 (en) 2023-09-14 2026-03-26 Eli Lilly And Company Pde1 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
WO2007150025A2 (en) * 2006-06-23 2007-12-27 Incyte Corporation Purinone derivatives as hm74a agonists
CA2671980C (en) * 2006-12-13 2015-05-05 Aska Pharmaceutical Co., Ltd. Quinoxaline derivatives
WO2008103357A1 (en) 2007-02-21 2008-08-28 E. I. Du Pont De Nemours And Company Fungicidal tricyclic 1,2,4-triazoles
EP2509983B1 (en) * 2009-11-16 2014-09-17 Merck Sharp & Dohme Corp. FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY
BR112013005439A2 (pt) 2010-09-07 2017-09-19 Astellas Pharma Inc compostos de quinoxalina
CN103874701A (zh) * 2011-09-09 2014-06-18 H.隆德贝克有限公司 吡啶化合物和其用途
MX357320B (es) 2012-06-18 2018-07-04 Dart Neuroscience Cayman Ltd Compuestos de la azolopirimidina-5-(6h)-ona de piridina sustituida.
US20140045856A1 (en) * 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
TW201629064A (zh) * 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
TWI609870B (zh) * 2016-02-12 2018-01-01 美國禮來大藥廠 Pde1抑制劑
JOP20170164A1 (ar) * 2016-08-25 2019-01-30 Lilly Co Eli مشتق ترايازولو بيرازينون مفيد كمثبط لـ pde1 بشري

Also Published As

Publication number Publication date
CN110914268B (zh) 2022-04-19
US11180503B2 (en) 2021-11-23
EP3661936B1 (en) 2021-12-22
TW201920175A (zh) 2019-06-01
CN110914268A (zh) 2020-03-24
EP3661936A1 (en) 2020-06-10
JP2020529413A (ja) 2020-10-08
ES2904938T3 (es) 2022-04-06
US20200123154A1 (en) 2020-04-23
JP6850396B2 (ja) 2021-03-31
TWI670271B (zh) 2019-09-01
WO2019027783A1 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
PE20221504A1 (es) Derivados de un inhibidor de fgfr
EA201991161A1 (ru) 7-фенилэтиламино-4h-пиримидо[4,5-d][1,3]оксазин-2-оновые соединения в качестве ингибиторов мутантных idh1 и idh2
MX2021013640A (es) Composiciones novedosas y metodos.
ES2609857T3 (es) 4-(8-metoxi-1-((1-metoxipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H-imidazo[4,5-C]quinolin-7-il)-3,5-dimetilisoxazol y su uso como inhibidor de bromodominios
CL2019000941A1 (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret.
MX2023009524A (es) Formas solidas cristalinas de inhibidor de bromodominio y extra-terminal (bet).
EA201691194A1 (ru) Стимуляторы ргц
UY37703A (es) Compuestos heteroarílicos bicíclicos 6-6 fusionados y su uso como inhibidores de lats
MX2023011675A (es) Beta-hidroxietilaminas heteroaril sustituidas para su uso en el tratamiento de hiperglucemia.
ECSP13012764A (es) COMPUESTO DE IMIDAZO[4,5-C]QUINOLIN-2-ONA Y SU USO COMO INHIBIDOR DUAL DE CINASA PI3/mTOR
PH12016502252A1 (en) Addition salts of (s)-2-(1-(6-amino-5-cyanopyrimidin-4-ylamino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[1,2-f][1,2,4]triazine-5-carbonitrile
MX2018005708A (es) Compuesto de 7-(tiazol-5-il)pirrolopirimidina como agonista de tlr7.
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
PE20151448A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim
CO6571861A2 (es) Derivado de 1,3,4,8-tetrahidro-2h-pirido[1,2-a]pirazina y su uso como inhibidor de la integrasa del vih
MX2020002814A (es) 7-bencil-4-(2-metilbencil)-2,4,6,7,8,9-hexahidroimidazo[1,2-a]pir ido[3,4-e]pirimidin-5(1h)-ona, sales de la misma y metodos de uso.
UY38358A (es) Inhibidores de sarcómeros cardíacos
PE20152033A1 (es) Heterociclos bicicliclos como inhibidores de fgfr
BR112019024300A2 (pt) Ativadores de guanilato ciclase solúvel com modo duplo de ação e inibidores da fosfodiesterase e usos dos mesmos
CL2020001464A1 (es) Péptidos antimicrobianos y métodos para usarlos.
MX2019013383A (es) Agente terapeutico para la demencia que combina derivado de pirazoloquinolina y memantina.
PE20170683A1 (es) Triazolo[4,5-d]pirimidinas como agonistas del receptor canabinoide 2
EP3957655A4 (en) ETHYLENE VINYL ALCOHOL COPOLYMER AND AQUEOUS SOLUTION WITH USE THEREOF
UY37250A (es) Derivados macrocíclicos de indol
PH12020551412A1 (en) Pharmaceutical composition including sodium alkyl sulfate

Legal Events

Date Code Title Description
FB Suspension of granting procedure